43857-0313 NDC - HZ FORMULA (BAPTISIA TINCTORIA, ECHINACEA (ANGUSTIFOLIA), LOMATIUM DISSECTUM, TABEBUIA IMPETIGINOSA, PROPOLIS, SPLEEN (SUIS), THYMUS (SUIS), THROIDINUM (SUIS), GELSEMIUM SEMPERVIRENS, LYCOPODIUM CLAVATUM, NUX VOMICA, CHLAMYDIA TRACHOMATIS, HERPES SIMPLEX 1 NOSODE, HERPES SIMPLEX 2 NOSODE, CANDIDA ALBICANS, HUMAN PAPILLOMAVIRUS, TRICHINELLA SPIRALIS)

Drug Information

  • Product NDC: 43857-0313
  • Proprietary Name: HZ Formula
  • Non Proprietary Name: Baptisia Tinctoria, Echinacea (Angustifolia), Lomatium Dissectum, Tabebuia Impetiginosa, Propolis, Spleen (Suis), Thymus (Suis), Throidinum (Suis), Gelsemium Sempervirens, Lycopodium Clavatum, Nux Vomica, Chlamydia Trachomatis, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Candida Albicans, Human Papillomavirus, Trichinella Spiralis
  • Active Ingredient(s): 3 [hp_X]/mL BAPTISIA TINCTORIA WHOLE; 30 [hp_X]/mL CANDIDA ALBICANS; 30 [hp_X]/mL CHLAMYDIA TRACHOMATIS; 3 [hp_X]/mL ECHINACEA ANGUSTIFOLIA WHOLE; 12 [hp_X]/mL GELSEMIUM SEMPERVIRENS ROOT; 30 [hp_X]/mL HUMAN HERPESVIRUS 1; 30 [hp_X]/mL HUMAN HERPESVIRUS 2; 30 [hp_X]/mL HUMAN PAPILLOMAVIRUS; 3 [hp_X]/mL LOMATIUM DISSECTUM ROOT; 12 [hp_X]/mL LYCOPODIUM CLAVATUM SPORE; 6 [hp_X]/mL PROPOLIS WAX; 12 [hp_X]/mL STRYCHNOS NUX-VOMICA SEED; 6 [hp_X]/mL SUS SCROFA SPLEEN; 6 [hp_X]/mL SUS SCROFA THYMUS; 3 [hp_X]/mL TABEBUIA IMPETIGINOSA BARK; 6 [hp_X]/mL THYROID; 30 [hp_X]/mL TRICHINELLA SPIRALIS
  • Administration Route(s): ORAL
  • Dosage Form(s): LIQUID
  • Pharmacy Class(es): Allergens [CS]; Allergens [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Fungal Proteins [CS]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Plant Allergenic Extract [EPC]; Plant Proteins [CS]; Seed Storage Proteins [CS]

Labeler Information

Field Name Field Value
Labeler Name: BioActive Nutritional, Inc
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:7/11/2014

Package Information

No. Package Code Package Description Billing Unit
143857-0313-130 mL in 1 BOTTLE, DROPPER (43857-0313-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC43857-0313The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEHZ FormulaThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEBaptisia Tinctoria, Echinacea (Angustifolia), Lomatium Dissectum, Tabebuia Impetiginosa, Propolis, Spleen (Suis), Thymus (Suis), Throidinum (Suis), Gelsemium Sempervirens, Lycopodium Clavatum, Nux Vomica, Chlamydia Trachomatis, Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Candida Albicans, Human Papillomavirus, Trichinella SpiralisThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE7/11/2014This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEBioActive Nutritional, IncName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEBAPTISIA TINCTORIA WHOLE; CANDIDA ALBICANS; CHLAMYDIA TRACHOMATIS; ECHINACEA ANGUSTIFOLIA WHOLE; GELSEMIUM SEMPERVIRENS ROOT; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN PAPILLOMAVIRUS; LOMATIUM DISSECTUM ROOT; LYCOPODIUM CLAVATUM SPORE; PROPOLIS WAX; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA SPLEEN; SUS SCROFA THYMUS; TABEBUIA IMPETIGINOSA BARK; THYROID; TRICHINELLA SPIRALISAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH3; 30; 30; 3; 12; 30; 30; 30; 3; 12; 6; 12; 6; 6; 3; 6; 30 
ACTIVE INGRED UNIT[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL 
PHARM CLASSESAllergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS] 

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 12/6/2025

Previous Code
Next Code